News › Industry News

Venus Concept Announces FDA 510(k) Clearance for Venus Viva MD

July 2, 2020

Venus Concept Inc., a global medical aesthetic technology leader, has announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD, a non-invasive device intended to be used by aesthetic-related physicians or dermatologists. It expands the company’s skin rejuvenation offerings beyond the Venus Viva and Venus Versa, which were introduced to the medical aesthetics market in 2015 and 2016, respectively.
Read more at Globe Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Moves to Reevaluate Several Peptides
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA